Latest Articles

Proteomics methods are now applied across a variety of scientific disciplines. In this article, we explore just some of the recent trends and advancements in high-throughput and single-cell proteomics.

Professors Jillian Banfield and Jennifer Doudna are embarking on an adventurous $70 million project to combat methane emissions by genetically editing microbes. Technology Networks interviewed the research team to learn more about the "audacious" project.

Predatory conferences are the ramshackle distant cousin of your regular scientific event, a Fyre Festival of science (without the involvement of Ja Rule). It is getting harder to separate fake conferences from real ones. Given this deluge of dodgy science, we have created a guide to spotting and avoiding predatory conferences.

Cryo electron microscopy (cryo EM) has revolutionized our understanding of the intricate molecular machinery that governs life. In this article, we discuss what cryo EM is, how it works, it's strengths, limitations and applications.

An automated and cost-effective workflow in immunopeptidomics, utilizing microfluidics technology, has been created that overcomes limitations in sample preparation and could be a powerful tool for tumor antigen discovery in sparse samples.

Featuring expert academic insights, this article will outline recent research advancements in synthetic biology, including novel methods and applications.

This article will discuss progress on the development of the Immune Cell Atlas, the different techniques and technologies contributing to its development and some of the interesting findings that are coming out of the project.

This article explores the various screening technologies used in the development of therapeutic antibodies and outlines the recent advances in this area.

Technology Networks had the pleasure of speaking with Walid A. Houry, professor of biochemistry at the University of Toronto, to find out about the discovery of compounds that can induce protease hyperactivation to kill cancer cells.

We spoke with Professor Perry N. Halkitis, dean, distinguished professor and champion of LGBTQ+ rights, about the US FDA's recent reversal of its time-based deferrals and screening questions specific to gay and bisexual men for assessing blood donation eligibility.